Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1989 Mar 1;169(3):737–754. doi: 10.1084/jem.169.3.737

Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes

PMCID: PMC2189255  PMID: 2538544

Abstract

The contribution of Escherichia coli hemolysin (ECH) to bacterial virulence has been considered mainly in context with its hemolytic properties. We here report that this prevalent bacterial cytolysin is the most potent leukocidin known to date. Very low concentrations (approximately 1 ng/ml) of ECH evoke membrane permeability defects in PMN (2-10 x 10(6) cells/ml) leading to an efflux of cellular ATP and influx of propidium iodide. The attacked cells do not appear to repair the membrane lesions. Human serum albumin, high density and low density lipoprotein, and IgG together protect erythrocytes and platelets against attack by even high doses (5-25 micrograms/ml) of ECH. In contrast, PMN are still permeabilized by ECH at low doses (50-250 ng/ml) in the presence of these plasma inactivators. Thus, PMN become preferred targets for attack by ECH in human blood and protein-rich body fluids. Kinetic studies demonstrate that membrane permeabilization is a rapid process, ATP-release commencing within seconds after application of toxin to leukocytes. It is estimated that membrane permeabilization ensues upon binding of approximately 300 molecules ECH/PMN. This process is paralleled by granule exocytosis, and by loss of phagocytic killing capacity of the cells. The recognition that ECH directly counteracts a major immune defence mechanism of the human organism through its attack on granulocytes under physiological conditions sheds new light on its possible role and potential importance as a virulence factor of E. coli.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnert-Hilger G., Bhakdi S., Gratzl M. Minimal requirements for exocytosis. A study using PC 12 cells permeabilized with staphylococcal alpha-toxin. J Biol Chem. 1985 Oct 15;260(23):12730–12734. [PubMed] [Google Scholar]
  2. Alouf J. E. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther. 1980;11(3):661–717. doi: 10.1016/0163-7258(80)90045-5. [DOI] [PubMed] [Google Scholar]
  3. Bader M. F., Thiersé D., Aunis D., Ahnert-Hilger G., Gratzl M. Characterization of hormone and protein release from alpha-toxin-permeabilized chromaffin cells in primary culture. J Biol Chem. 1986 May 5;261(13):5777–5783. [PubMed] [Google Scholar]
  4. Baluyut C. S., Simonson R. R., Bemrick W. J., Maheswaran S. K. Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. Am J Vet Res. 1981 Nov;42(11):1920–1926. [PubMed] [Google Scholar]
  5. Bentwood B. J., Henson P. M. The sequential release of granule constitutents from human neutrophils. J Immunol. 1980 Feb;124(2):855–862. [PubMed] [Google Scholar]
  6. Bhakdi S., Füssle R., Tranum-Jensen J. Staphylococcal alpha-toxin: oligomerization of hydrophilic monomers to form amphiphilic hexamers induced through contact with deoxycholate detergent micelles. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5475–5479. doi: 10.1073/pnas.78.9.5475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bhakdi S., Mackman N., Nicaud J. M., Holland I. B. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun. 1986 Apr;52(1):63–69. doi: 10.1128/iai.52.1.63-69.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bhakdi S., Muhly M., Mannhardt U., Hugo F., Klapettek K., Mueller-Eckhardt C., Roka L. Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J Exp Med. 1988 Aug 1;168(2):527–542. doi: 10.1084/jem.168.2.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bhakdi S., Tranum-Jensen J. Damage to cell membranes by pore-forming bacterial cytolysins. Prog Allergy. 1988;40:1–43. [PubMed] [Google Scholar]
  10. Bhakdi S., Tranum-Jensen J. Membrane damage by complement. Biochim Biophys Acta. 1983 Aug 11;737(3-4):343–372. doi: 10.1016/0304-4157(83)90006-0. [DOI] [PubMed] [Google Scholar]
  11. Bhakdi S., Tranum-Jensen J., Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect Immun. 1985 Jan;47(1):52–60. doi: 10.1128/iai.47.1.52-60.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bhakdi S., Tranum-Jensen J., Utermann G., Füssle R. Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem. 1983 May 10;258(9):5899–5904. [PubMed] [Google Scholar]
  13. Brooks H. J., O'Grady F., McSherry M. A., Cattell W. R. Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. J Med Microbiol. 1980 Feb;13(1):57–68. doi: 10.1099/00222615-13-1-57. [DOI] [PubMed] [Google Scholar]
  14. Bruning J. W., Kardol M. J., Arentzen R. Carboxyfluorescein fluorochromasia assays. I. Non-radioactively labeled cell mediated lympholysis. J Immunol Methods. 1980;33(1):33–44. doi: 10.1016/0022-1759(80)90080-0. [DOI] [PubMed] [Google Scholar]
  15. Cavalieri S. J., Bohach G. A., Snyder I. S. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol Rev. 1984 Dec;48(4):326–343. doi: 10.1128/mr.48.4.326-343.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cavalieri S. J., Snyder I. S. Cytotoxic activity of partially purified Escherichia coli alpha haemolysin. J Med Microbiol. 1982 Feb;15(1):11–21. doi: 10.1099/00222615-15-1-11. [DOI] [PubMed] [Google Scholar]
  17. Cavalieri S. J., Snyder I. S. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. Infect Immun. 1982 May;36(2):455–461. doi: 10.1128/iai.36.2.455-461.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cooke E. M., Ewins S. P. Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol. 1975 Feb;8(1):107–111. doi: 10.1099/00222615-8-1-107. [DOI] [PubMed] [Google Scholar]
  19. Detwiler T. C., Feinman R. D. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry. 1973 Jun 19;12(13):2462–2468. doi: 10.1021/bi00737a015. [DOI] [PubMed] [Google Scholar]
  20. Evans D. J., Jr, Evans D. G., Höhne C., Noble M. A., Haldane E. V., Lior H., Young L. S. Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol. 1981 Jan;13(1):171–178. doi: 10.1128/jcm.13.1.171-178.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Feinman R. D., Lubowsky J., Charo I., Zabinski M. P. The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med. 1977 Jul;90(1):125–129. [PubMed] [Google Scholar]
  22. Felmlee T., Pellett S., Welch R. A. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol. 1985 Jul;163(1):94–105. doi: 10.1128/jb.163.1.94-105.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Füssle R., Bhakdi S., Sziegoleit A., Tranum-Jensen J., Kranz T., Wellensiek H. J. On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol. 1981 Oct;91(1):83–94. doi: 10.1083/jcb.91.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gadeberg O. V., Orskov I. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Infect Immun. 1984 Jul;45(1):255–260. doi: 10.1128/iai.45.1.255-260.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gadeberg O. V., Orskov I., Rhodes J. M. Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. Infect Immun. 1983 Jul;41(1):358–364. doi: 10.1128/iai.41.1.358-364.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Goebel W., Hedgpeth J. Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J Bacteriol. 1982 Sep;151(3):1290–1298. doi: 10.1128/jb.151.3.1290-1298.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hacker J., Hughes C., Hof H., Goebel W. Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun. 1983 Oct;42(1):57–63. doi: 10.1128/iai.42.1.57-63.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Himmel M. E., Yates M. D., Lauerman L. H., Squire P. G. Purification and partial characterization of a macrophage cytotoxin from Pasteurella haemolytica. Am J Vet Res. 1982 May;43(5):764–767. [PubMed] [Google Scholar]
  29. Hirayama T., Kato I. Mode of cytotoxic action of pseudomonal leukocidin on phosphatidylinositol metabolism and activation of lysosomal enzyme in rabbit leukocytes. Infect Immun. 1984 Jan;43(1):21–27. doi: 10.1128/iai.43.1.21-27.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hirayama T., Noda M., Matsuda F., Nagamori M., Kato I. Binding of pseudomonal leukocidin to rabbit polymorphonuclear leukocytes. Infect Immun. 1984 Dec;46(3):631–634. doi: 10.1128/iai.46.3.631-634.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hughes C., Hacker J., Roberts A., Goebel W. Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun. 1983 Feb;39(2):546–551. doi: 10.1128/iai.39.2.546-551.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hugo F., Arvand M., Reichwein J., Mackman N., Holland I. B., Bhakdi S. Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli. J Clin Microbiol. 1987 Jan;25(1):26–30. doi: 10.1128/jcm.25.1.26-30.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Imagawa D. K., Osifchin N. E., Paznekas W. A., Shin M. L., Mayer M. M. Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6647–6651. doi: 10.1073/pnas.80.21.6647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Jorgensen S. E., Hammer R. F., Wu G. K. Effects of a single hit from the alpha hemolysin produced by Escherichia coli on the morphology of sheep erythrocytes. Infect Immun. 1980 Mar;27(3):988–994. doi: 10.1128/iai.27.3.988-994.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Jorgensen S. E., Mulcahy P. F., Wu G. K., Louis C. F. Calcium accumulation in human and sheep erythrocytes that is induced by Escherichia coli hemolysin. Toxicon. 1983;21(5):717–727. doi: 10.1016/0041-0101(83)90277-5. [DOI] [PubMed] [Google Scholar]
  36. Kaehler K. L., Markham R. J., Muscoplat C. C., Johnson D. W. Evidence of species specificity in the cytocidal effects of Pasteurella haemolytica. Infect Immun. 1980 Nov;30(2):615–616. doi: 10.1128/iai.30.2.615-616.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kolber M. A., Quinones R. R., Gress R. E., Henkart P. A. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF). J Immunol Methods. 1988 Apr 6;108(1-2):255–264. doi: 10.1016/0022-1759(88)90427-9. [DOI] [PubMed] [Google Scholar]
  38. Koronakis V., Cross M., Senior B., Koronakis E., Hughes C. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol. 1987 Apr;169(4):1509–1515. doi: 10.1128/jb.169.4.1509-1515.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lakhanpal S., Gonchoroff N. J., Katzmann J. A., Handwerger B. S. A flow cytofluorometric double staining technique for simultaneous determination of human mononuclear cell surface phenotype and cell cycle phase. J Immunol Methods. 1987 Jan 26;96(1):35–40. doi: 10.1016/0022-1759(87)90364-4. [DOI] [PubMed] [Google Scholar]
  40. Lo R. Y., Shewen P. E., Strathdee C. A., Greer C. N. Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12. Infect Immun. 1985 Dec;50(3):667–671. doi: 10.1128/iai.50.3.667-671.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lo R. Y., Strathdee C. A., Shewen P. E. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect Immun. 1987 Sep;55(9):1987–1996. doi: 10.1128/iai.55.9.1987-1996.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ludwig A., Vogel M., Goebel W. Mutations affecting activity and transport of haemolysin in Escherichia coli. Mol Gen Genet. 1987 Feb;206(2):238–245. doi: 10.1007/BF00333579. [DOI] [PubMed] [Google Scholar]
  43. Mackman N., Nicaud J. M., Gray L., Holland I. B. Secretion of haemolysin by Escherichia coli. Curr Top Microbiol Immunol. 1986;125:159–181. doi: 10.1007/978-3-642-71251-7_10. [DOI] [PubMed] [Google Scholar]
  44. Markert M., Andrews P. C., Babior B. M. Measurement of O2- production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol. 1984;105:358–365. doi: 10.1016/s0076-6879(84)05048-5. [DOI] [PubMed] [Google Scholar]
  45. McEwen B. F., Arion W. J. Permeabilization of rat hepatocytes with Staphylococcus aureus alpha-toxin. J Cell Biol. 1985 Jun;100(6):1922–1929. doi: 10.1083/jcb.100.6.1922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Menestrina G., Mackman N., Holland I. B., Bhakdi S. Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta. 1987 Nov 27;905(1):109–117. doi: 10.1016/0005-2736(87)90014-9. [DOI] [PubMed] [Google Scholar]
  47. Minshew B. H., Jorgensen J., Counts G. W., Falkow S. Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates. Infect Immun. 1978 Apr;20(1):50–54. doi: 10.1128/iai.20.1.50-54.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Noda M., Hirayama T., Matsuda F., Kato I. An early effect of the S component of staphylococcal leukocidin on methylation of phospholipid in various leukocytes. Infect Immun. 1985 Oct;50(1):142–145. doi: 10.1128/iai.50.1.142-145.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Noda M., Kato I., Hirayama T., Matsuda F. Mode of action of staphylococcal leukocidin: effects of the S and F components on the activities of membrane-associated enzymes of rabbit polymorphonuclear leukocytes. Infect Immun. 1982 Jan;35(1):38–45. doi: 10.1128/iai.35.1.38-45.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Rennie R. P., Freer J. H., Arbuthnott J. P. The kinetics of erythrocyte lysis by Escherichia coli haemolysin. J Med Microbiol. 1974 May;7(2):189–195. doi: 10.1099/00222615-7-2-189. [DOI] [PubMed] [Google Scholar]
  51. Rink T. J., Tsien R. Y., Pozzan T. Cytoplasmic pH and free Mg2+ in lymphocytes. J Cell Biol. 1982 Oct;95(1):189–196. doi: 10.1083/jcb.95.1.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Scharmann W. Cytotoxic effects of leukocidin from Pseudomonas aeruginosa on polymorphonuclear leukocytes from cattle. Infect Immun. 1976 Mar;13(3):836–843. doi: 10.1128/iai.13.3.836-843.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Scharmann W. Interaction of purified leukocidin from Pseudomonas aeruginosa with Bovine polymorphonuclear leukocytes. Infect Immun. 1976 Apr;13(4):1046–1053. doi: 10.1128/iai.13.4.1046-1053.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Scharmann W. Purification and characterization of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol. 1976 Apr;93(2):292–302. doi: 10.1099/00221287-93-2-292. [DOI] [PubMed] [Google Scholar]
  55. Schmidt C., Schmieger H. Selective transduction of recombinant plasmids with cloned pac sites by Salmonella phage P22. Mol Gen Genet. 1984;196(1):123–128. doi: 10.1007/BF00334103. [DOI] [PubMed] [Google Scholar]
  56. Seeger W., Bauer M., Bhakdi S. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest. 1984 Sep;74(3):849–858. doi: 10.1172/JCI111502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Seeger W., Suttorp N., Hellwig A., Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol. 1986 Aug 15;137(4):1286–1293. [PubMed] [Google Scholar]
  58. Shewen P. E., Wilkie B. N. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982 Jan;35(1):91–94. doi: 10.1128/iai.35.1.91-94.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Steadman R., Topley N., Jenner D. E., Davies M., Williams J. D. Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes. Infect Immun. 1988 Apr;56(4):815–822. doi: 10.1128/iai.56.4.815-822.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Strathdee C. A., Lo R. Y. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infect Immun. 1987 Dec;55(12):3233–3236. doi: 10.1128/iai.55.12.3233-3236.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Suttorp N., Seeger W., Dewein E., Bhakdi S., Roka L. Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: role of calcium. Am J Physiol. 1985 Jan;248(1 Pt 1):C127–C134. doi: 10.1152/ajpcell.1985.248.1.C127. [DOI] [PubMed] [Google Scholar]
  62. Welch R. A., Dellinger E. P., Minshew B., Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature. 1981 Dec 17;294(5842):665–667. doi: 10.1038/294665a0. [DOI] [PubMed] [Google Scholar]
  63. Welch R. A., Hull R., Falkow S. Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. Infect Immun. 1983 Oct;42(1):178–186. doi: 10.1128/iai.42.1.178-186.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Welch R. A. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect Immun. 1987 Sep;55(9):2183–2190. doi: 10.1128/iai.55.9.2183-2190.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Woodin A. M., Wieneke A. A. The interaction of eucocidin with the cell membrane of the polymorponuclearleucocyte. Biochem J. 1966 May;99(2):479–492. doi: 10.1042/bj0990479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zwadyk P., Jr, Snyder I. S. Purification and kinetic studies of the hemolysin from Escherichia coli. Can J Microbiol. 1971 Jun;17(6):741–745. doi: 10.1139/m71-118. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES